ezogabine has been researched along with phenylbutazone in 1 studies
| Studies (ezogabine) | Trials (ezogabine) | Recent Studies (post-2010) (ezogabine) | Studies (phenylbutazone) | Trials (phenylbutazone) | Recent Studies (post-2010) (phenylbutazone) |
|---|---|---|---|---|---|
| 383 | 26 | 241 | 6,291 | 317 | 125 |
| Protein | Taxonomy | ezogabine (IC50) | phenylbutazone (IC50) |
|---|---|---|---|
| fMet-Leu-Phe receptor | Homo sapiens (human) | 5.3 | |
| Cyclooxygenase-2 | Canis lupus familiaris (dog) | 3.79 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, TK; Ensom, MH; Kiang, TK | 1 |
1 review(s) available for ezogabine and phenylbutazone
| Article | Year |
|---|---|
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |